Last $70.39 USD
Change Today +0.23 / 0.33%
Volume 1.4M
LLY On Other Exchanges
Symbol
Exchange
New York
Mexico
SIX Swiss Ex
Sao Paulo
EN Paris
Frankfurt
As of 8:04 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Anne Nobles M.A.,J.D.

Former Chief Ethics & Compliance Officer, Senior Vice President of Enterprise Risk Management and Member of Operations Committee, Eli Lilly and Company
AgeTotal Calculated CompensationThis person is connected to 25 board members in 3 different organizations across 3 different industries.

See Board Relationships
57--

Background*

Ms. Anne Nobles, M.A., J.D. served as Senior Vice President of Enterprise Risk Management for Eli Lilly and Company from April 2009 to January 1, 2013 and Chief Ethics & Compliance Officer from June 2007 to January 1, 2013. Ms. Nobles served as Vice President of Compliance and Enterprise Risk Management of Eli Lilly since May 2007 and also served as its Chief Compliance Officer since 2007 until April 2009. She served as Strattera (TM) Product Team Leader at Eli Lilly ...

Read Full Background

Corporate Headquarters*

Lilly Corporate Center
Indianapolis, Indiana 46285

United States

Phone: 317-276-2000
Fax: --

Board Members Memberships*

Director
Director
Director

Education*

MA 1979
Harvard University
BA 1978
Harvard University
JD 1984
Georgetown University Law School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LLY:US $70.39 USD +0.23

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$1.9M
Erez Vigodman Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
kr15.2M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELI LILLY & CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.